Avacta Group (AVCT), a clinical stage oncology drug company, announced that the first-in-human Phase I trial (ALS-6000-101) of AVA6000 Pro-doxorubicin will advance to the fourth dose cohort of patients following
Avacta Group (AVCT), a clinical stage oncology drug company, announced that the first-in-human Phase I trial (ALS-6000-101) of AVA6000 Pro-doxorubicin will advance to the fourth dose cohort of patients following
A round-up of the London-listed oil and gas, energy announcements over the past week. Plus the geopolitical news from around the globe.
Picking up from last week’s blog, UJO, OEX delivered news, PANR‘s Twitter feed is on fire along with ANGS, updating holders, the two best Twitter feeds in my humble opinion
What a week across the oil & gas sector, news due next week on CLON, ANGS is within touching distance and Share Talk is looking to talk to both companies, plus
What a week, so much going on and news due next week on CLON, ANGS is within touching distance, plus a monster drill to spud in July when PANR go
Gulf Keystone, a leading independent operator and producer in the Kurdistan Region of Iraq, is pleased to announce that the Board has approved the declaration of a special dividend of
Pensana (PRE) said it has completed a Front End Engineering Design and Value Engineering Study into establishing a UK-based supply of the magnet metal rare earths vital for the electric
Audioboom (BOOM), the leading global podcast company where there are apparently multiple bidders waiting in the wings, said that on 3 March, Michael Tobin OBE, the Chairman of the Company,
Zak Mir takes a charting look at some of the most followed small caps. Today’s selection includes Amur, Arc, Contango, Gulf, i3, Origo, Oilex, Premier, Petrotal, Pires, Tertiary, THG.
Given the way that in the past couple of weeks there has clearly been some end of tax year/waiting for the new ISA reset on April 6 jiggery-pokery in the
Although the London stock market did not remain open long enough to feel the full benefit of the fresh bullishness on international equity markets, the near one percent gain for